TRACER is a company specialised in first-in-human studies using nuclear and optical molecular imaging techniques. They accelerate clinical trials by utilising in-human microdosing techniques, providing accurate data on whether a compound reaches the target site in the body.

Services include:
- First-in-human studies
- Nuclear molecular imaging
- Optical molecular imaging
- In-human microdosing techniques
- Clinical trial acceleration

Tracer is committed to advancing drug development and improving clinical outcomes through innovative imaging solutions. For more information, please visit tracercro.com.